Sepsis Testing Trial Ends In $2.1M Patent Verdict In Del.
A medical device startup failed to convince jurors in Delaware that a rival's patent covering a new method of testing for sepsis was already covered by decades-old research, leading to an...To view the full article, register now.
Already a subscriber? Click here to view full article